The detection of these hub genes in all AML samples demonstrates the reliability of CGMega interpretation, and suggests the potential usage as AML gene panels of those five new hub genes, including ESR1, HDAC1, FYN, LYN, and GRB2. The gene discussed is FYN; the disease is acute myeloid leukemia.